Meet the Expert
Cystic Lung Disease in BHD
Cystic Lung Disease in BHD
Highlights from the 2022 International LAM Research Conference
Chromophobe RCC: New Concepts in Pathogenesis
Ig Nobel Prize Ceremony 2017
Intro to Biomedical Research by Dr. Henske
Intro to Biomedical Research by Dr. Henske
ACT Now to Help Unlock the Cure to Tuberous Sclerosis Complex
Using Research Discoveries in Treatment
LAM: From Puzzle to Treatment
The Air We Breathe
Interview with Professor Elizabeth Henske
Understanding the Importance of Clinical Trials in Tuberous Sclerosis Complex Research
ARRA Funding at BWH
2014 WORLD TSC CONFERENCE
Emerging Treatments -- mTOR Inhibitors and Beyond
Emerging Treatments -- mTOR Inhibitors and Beyond
2014 WORLD TSC CONFERENCE
Lung Involvement in TSC and Treatment Options
Lung Involvement in TSC and Treatment Options
Spotlight on Chromophobe RCC
Interview with Lisa Henske
Interview with Lisa Henske
Today’s Voice of Kidney Cancer is Dr. Elizabeth (Lisa) Henske, who runs the Henske Lab at Brigham and Women’s Hospital and Harvard Medical School in Boston. One of her principal areas of research is chromophobe renal cell carcinoma (chRCC). She’s also one of the newest members of the KCCure scientific advisory board. We’re grateful to Dr. Henske for donating her time to answer a few questions about her work in chRCC.